“39-Week Intravenous Injection Toxicity and Toxicokinetic Study of Eteplirsen in Sexually Mature Male Cynomolgus Monkeys with an 8-Week Recovery”
✓ VerifiedFDA pharmacology/toxicology review, p. 74Source ↗
Pivotal GLP studies
39-week IV male monkey; 10-week IV juvenile rat (PND14-77); 26-week IV mdx mouse with surrogate AVI-4225
“Pivotal toxicology studies of eteplirsen were conducted in male monkeys (39-week study) and juvenile male rats (10-week study). A 26-week study was conducted with a mouse-specific surrogate (AVI-4225) in male transgenic mdx mice.”
✓ VerifiedFDA pharmacology/toxicology review, p. 25Source ↗
Route in tox
IV weekly (clinical route); SC arms in 12-week mouse and monkey studies
“In the pivotal studies, eteplirsen was administered weekly at doses of 0, 5, 40, and 320 mg/kg IV; the 12-week study also included a group receiving 320 mg/kg SC.”
✓ VerifiedFDA pharmacology/toxicology review, p. 17Source ↗